January 09, 2026 10:33 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Trump backs bill threatening 500% tariffs on India over Russian oil trade | ED alleges Mamata 'forcibly removed documents' during IPAC raids, CM calls Amit Shah 'nasty Home Minister' | 'Nasty Home Minister!': Mamata slams Amit Shah after ED raids IPAC office and firm head Pratik Jain | ED raids IPAC office, Pratik Jain’s home in coal scam probe; Mamata Banerjee rushes in, takes on BJP | TMC moves Supreme Court against ECI over SIR, alleges ‘WhatsApp Commission’ in voter revision | Madurai HC shocks DMK! Hilltop Karthigai Deepam allowed, court slams ‘unnecessary politicisation’ – Hindus celebrate big victory! | Suresh Kalmadi, ex-Union Minister and controversial Commonwealth Games chief, passes away at 81 | Bangladesh bans IPL telecast after KKR drops Mustafizur Rahman | ‘Qualitatively different’: Supreme Court shuts bail door on Umar Khalid, Sharjeel Imam in Delhi riots case | ‘Modi is a good guy,’ says Trump — then comes the tariff threat over Russian oil

UN hails landmark pricing deal for faster rollout of ‘game-changing’ HIV treatment

| @indiablooms | Sep 22, 2017, at 04:58 pm
New York, Sept 22(Just Earth News): Senior United Nations officials on Thursday welcomed a breakthrough pricing agreement by global partners to accelerate the availability in low- and middle-income countries of the first affordable, generic, single-pill HIV treatment regimen.

“What we are talking about on Thursday with this life-changing announcement is about the quality of medicine, is about equity, is about the dignity, is about access to medicine as a human right,” Michel Sidibé, Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS), told a press conference at UN Headquarters.

The pricing agreement, he explained, will help ensure that the treatment will be made available to 92 countries, and people there will be able to benefit from “one of the best medicines we have” for first-line treatment.

At around $75 per person per year, the HIV treatment regimen containing dolutegravir (DTG) will be available to public-sector purchasers in these countries.

The agreement is expected to accelerate treatment rollout as part of global efforts to reach all 36.7 million people living with HIV with high-quality antiretroviral therapy. UNAIDS estimates that in 2016, 19.5 million – or just over half of all people living with HIV – had access to the life-saving medicines.

DTG, a best-in-class integrase inhibitor, is widely used in high-income countries and is recommended by the World Health Organization (WHO) as an alternative first-line HIV regimen. It is also a preferred treatment by the United States Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, among others.

WHO Director-General Tedros Adhanom also welcomed the agreement, stating that “this will save lives for the most vulnerable, bringing the world closer to the elimination of HIV […] WHO will support countries in the safe introduction and a swift transition to this game-changing new treatment.”

The agreement was announced by the Governments of South Africa and Kenya, together with UNAIDS and many other partners.

Earlier on Thursday, during an event entitled “Fast-Track: Quickening the pace of action to end AIDS” held on the sidelines of the General Assembly, Sidibé called on world leaders to maintain “global solidarity” to end AIDS.

UNAIDS leads global efforts to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths.

Photo: © Masaru Goto / World Bank

 

Source: www.justearthnews.com

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.